PT Hanjaya Mandala Sampoerna Tbk - PHJMF

PHJMF Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
PHJMF	2.6	0	22.7	-20	3.1	-20	-42.9	-75.3	-80.9	-84.6
S&P 500	0.9	0.9	2.0	3.4	8.7	24.7	37.2	82.1	193.2	34153.9

Compare PHJMF with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	PHJMF
name	PT Hanjaya Mandala Sampoerna Tbk
price	0.04
changes percentage	2.5641
change	0.001
day low	0.039
day high	0.04
year high	0.07
year low	0.03
market cap	4652720000
price avg 50	0.039
price avg 200	0.04275
exchange	PNK
volume	91188
avg volume	54911
open	0.039
previous close	None
eps	0.01
pe	4
earnings announcement	2025-03-25T10:59:00.000+0000
shares outstanding	116318000000
timestamp	2025-01-21 20:00:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 62.0%

Overall Quarterly Financial Health: 65.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	53106365000000	111211321000000	-52.25
gross profit	19330397000000	17158198000000	12.66
gross profit ratio	0.36	0.15	135.92
research and development expenses	55261000000	57285000000	-3.53
operating expenses	19330397000000	9405015000000	105.53
interest income	715647000000	463037000000	54.56
interest expense	24732000000	22046000000	12.18
ebitda	10335945000000	8295105000000	24.60
ebitdaratio	0.19	0.07	160.93
operating income	8964075000000	8295105000000	8.06
operating income ratio	0.17	0.07	126.30
net income	8096811000000	6323744000000	28.04
net income ratio	0.15	0.06	168.13
eps	69.61	54.37	28.03

Overall Score of Annual Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 53,106,365 million in 2023 from 111,211,321 million in 2022 representing a change of -52.25%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 19,330,397 million in 2023 from 17,158,198 million in 2022 representing a change of 12.66%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 19,330,397 million in 2023 from 9,405,015 million in 2022 representing a change of 105.53%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Operating Income: Operating income increased to 8,964,075 million in 2023 from 8,295,105 million in 2022 representing a change of 8.06%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 8,096,811 million in 2023 from 6,323,744 million in 2022 representing a change of 28.04%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 69.61 in 2023 from 69.61 in 2022 representing a change of 28.03%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 55,261 million in 2023 from 57,285 million in 2022 representing a change of -3.53%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 10,335,945 million in 2023 from 8,295,105 million in 2022 representing a change of 24.6%. The decrease in EBITDA indicates declined operational efficiency and profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
revenue	30651101000000	11153956000000	174.80
gross profit	5070632000000	3854188000000	31.56
gross profit ratio	0.17	0.35	-52.12
research and development expenses	0	0	NaN
operating expenses	2667902000000	2709650000000	-1.54
interest income	171049000000	170208000000	0.49
interest expense	6780000000	6788000000	-0.12
ebitda	2453615000000	1443730000000	69.95
ebitdaratio	0.08	0.13	-38.16
operating income	2402730000000	1144538000000	109.93
operating income ratio	0.08	0.1	-23.61
net income	1907718000000	1069684000000	78.34
net income ratio	0.06	0.1	-35.10
eps	16.4	9.2	78.26

Overall Score of Quarterly Income Statement

1.0 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 30,651,101 million in 2024Q3 from 11,153,956 million in 2024Q2 representing a change of 174.8%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 5,070,632 million in 2024Q3 from 3,854,188 million in 2024Q2 representing a change of 31.56%. This indicates a sales profitability growth, which is a positive sign for the company.

  Operating Expenses: Operating Expenses decreased to 2,667,902 million in 2024Q3 from 2,709,650 million in 2024Q2 representing a change of -1.54%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 2,453,615 million in 2024Q3 from 1,443,730 million in 2024Q2 representing a change of 69.95%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 2,402,730 million in 2024Q3 from 1,144,538 million in 2024Q2 representing a change of 109.93%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 1,907,718 million in 2024Q3 from 1,069,684 million in 2024Q2 representing a change of 78.34%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 16.4 in 2024Q3 from 16.4 in 2024Q2 representing a change of 78.26%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	55316264000000	54786992000000	0.97
total liabilities	25446411000000	26616824000000	-4.40
total equity	29869853000000	28170168000000	6.03
cash and cash equivalents	2695159000000	3283118000000	-17.91
short term investments	0	-1774463000000	100.00
long term investments	85792000000	1862554000000	-95.39
total current assets	40066044000000	41362998000000	-3.14
total non current assets	15250220000000	13423994000000	13.60
total current liabilities	23302684000000	24545594000000	-5.06
total non current liabilities	2143727000000	2071230000000	3.50
common stock	465272000000	465272000000	0.00
retained earnings	8071928000000	6370419000000	26.71
total debt	445289000000	484627000000	-8.12

Overall Score of Annual Balance Sheet

0.78 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 55,316,264 million in 2023 from 54,786,992 million in 2022 representing a change of 0.97%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 25,446,411 million in 2023 from 26,616,824 million in 2022 representing a change of -4.4%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 29,869,853 million in 2023 from 28,170,168 million in 2022 representing a change of 6.03%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 0 million in 2023 from -1,774,463 million in 2022 representing a change of 100.0%. This indicates an increase in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities decreased to 23,302,684 million in 2023 from 24,545,594 million in 2022 representing a change of -5.06%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 8,071,928 million in 2023 from 6,370,419 million in 2022 representing a change of 26.71%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 445,289 million in 2023 from 484,627 million in 2022 representing a change of -8.12%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 2,695,159 million in 2023 from 3,283,118 million in 2022 representing a change of -17.91%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 40,066,044 million in 2023 from 41,362,998 million in 2022 representing a change of -3.14%. This indicates a worsen liquidity position.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
total assets	53247388000000	51023683000000	4.36
total liabilities	26214801000000	25917246000000	1.15
total equity	27032587000000	25106437000000	7.67
cash and cash equivalents	6029094000000	7052904000000	-14.52
short term investments	0	0	NaN
long term investments	0	437174000000	-100.00
total current assets	37404240000000	36141838000000	3.49
total non current assets	15843148000000	14881845000000	6.46
total current liabilities	24138290000000	23775508000000	1.53
total non current liabilities	2076511000000	2141738000000	-3.05
common stock	465272000000	465272000000	0.00
retained earnings	5235532000000	3327814000000	57.33
total debt	390876000000	508684000000	-23.16

Overall Score of Quarterly Balance Sheet

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 53,247,388 million in 2024Q3 from 51,023,683 million in 2024Q2 representing a change of 4.36%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 27,032,587 million in 2024Q3 from 25,106,437 million in 2024Q2 representing a change of 7.67%. This indicates an increase in shareholders' equity.

  Total Current Assets: Total Current Assets increased to 37,404,240 million in 2024Q3 from 36,141,838 million in 2024Q2 representing a change of 3.49%. This indicates a better liquidity position.

  Retained Earnings: Retained Earnings increased to 5,235,532 million in 2024Q3 from 3,327,814 million in 2024Q2 representing a change of 57.33%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 390,876 million in 2024Q3 from 508,684 million in 2024Q2 representing a change of -23.16%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 26,214,801 million in 2024Q3 from 25,917,246 million in 2024Q2 representing a change of 1.15%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 6,029,094 million in 2024Q3 from 7,052,904 million in 2024Q2 representing a change of -14.52%. This indicates a decrease in available liquid assets.

  Total Current Liabilities: Total Current Liabilities increased to 24,138,290 million in 2024Q3 from 23,775,508 million in 2024Q2 representing a change of 1.53%. This indicates a higher short-term debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-587959000000	-14560538000000	95.96
operating cash flow	6282144000000	7356942000000	-14.61
free cash flow	4580237000000	5178120000000	-11.55
capital expenditure	-1701907000000	-2178822000000	21.89
depreciation and amortization	1110362000000	1107062000000	0.30
deferred income tax	0	0	NaN
stock based compensation	73700000000	71300000000	3.37
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	6446000000	-100.00
investments in property plant and equipment	-1701907000000	-2178822000000	21.89
net cash used for investing activites	-328207000000	-14274572000000	97.70
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-6362599000000	-7362934000000	13.59
net cash used provided by financing activities	-6541896000000	-7641302000000	14.39
cash at end of period	2695159000000	3283118000000	-17.91
accounts receivables	0	0	NaN
cash at beginning of period	3283118000000	17843656000000	-81.60

Overall Score of Annual Cashflow Statement

0.33 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -587,959 million in 2023 from -14,560,538 million in 2022 representing a change of 95.96%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Dividends Paid: Dividends Paid increased to -6,362,599 million in 2023 from -7,362,934 million in 2022 representing a change of 13.59%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 6,282,144 million in 2023 from 7,356,942 million in 2022 representing a change of -14.61%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 4,580,237 million in 2023 from 5,178,120 million in 2022 representing a change of -11.55%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -1,701,907 million in 2023 from -2,178,822 million in 2022 representing a change of 21.89%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to 73,700 million in 2023 from 71,300 million in 2022 representing a change of 3.37%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
operating cash flow	0	5262513000000	-100.00
free cash flow	-314809000000	4566315000000	-106.89
capital expenditure	-314809000000	-696198000000	54.78
depreciation and amortization	0	299192000000	-100.00
deferred income tax	0	0	NaN
stock based compensation	0	20600000000	-100.00
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	60678000000	-100.00
investments in property plant and equipment	-314809000000	-696198000000	54.78
net cash used for investing activites	-3780675000000	4766758000000	-179.31
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	-8060843000000	100.00
net cash used provided by financing activities	-59810000000	-8069817000000	99.26
net change in cash	-1023810000000	1959454000000	-152.25
cash at end of period	6029094000000	7052904000000	-14.52
cash at beginning of period	7052904000000	5093450000000	38.47

Overall Score of Quarterly Cashflow Statement

0.33 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -1,023,810 million in 2024Q3 from 1,959,454 million in 2024Q2 representing a change of -152.25%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 0 million in 2024Q3 from 5,262,513 million in 2024Q2 representing a change of -100.0%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to -314,809 million in 2024Q3 from 4,566,315 million in 2024Q2 representing a change of -106.89%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -314,809 million in 2024Q3 from -696,198 million in 2024Q2 representing a change of 54.78%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

• 📈 Positive Indicators

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2024Q3 from 20,600 million in 2024Q2 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Dividends Paid: Dividends Paid increased to 0 million in 2024Q3 from -8,060,843 million in 2024Q2 representing a change of 100.0%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	402.62	956.1	-57.89
net income per share	69.61	54.37	28.04
operating cash flow per share	54.01	54.37	-0.66
free cash flow per share	39.38	35.63	10.50
cash per share	23.64	24.96	-5.29
book value per share	256.79	242.18	6.03
tangible book value per share	256.28	241.66	6.05
shareholders equity per share	256.79	242.18	6.03
interest debt per share	4.19	4.36	-3.88
market cap	103523088441000	97707184596000	5.95
enterprise value	101273218441000	94908693596000	6.71
pe ratio	12.79	15.45	-17.25
price to sales ratio	2.21	0.88	151.60
pocfratio	16.48	15.45	6.65
pfcf ratio	22.6	23.57	-4.12
pb ratio	3.47	3.47	-0.08
ptb ratio	3.47	3.47	-0.08
ev to sales	2.16	0.85	153.39
enterprise value over ebitda	8.83	10.06	-12.22
ev to operating cash flow	16.12	15.01	7.41
ev to free cash flow	22.11	22.9	-3.44
earnings yield	0.08	0.06	20.85
free cash flow yield	0.04	0.04	4.29
debt to equity	0.01	0.02	-13.35
debt to assets	0.01	0.01	-9.00
net debt to ebitda	-0.2	-0.3	33.86
current ratio	1.72	1.69	2.03
interest coverage	214.72	376.26	-42.93
income quality	0.78	1	-22.41
dividend yield	0.06	0.08	-18.44
payout ratio	0.79	1.16	-32.51
sales general and administrative to revenue	0.06	0.02	153.88
research and ddevelopement to revenue	0.0	0.0	129.08
intangibles to total assets	0.0	0.0	-0.96
capex to operating cash flow	0.27	0.34	-21.37
capex to revenue	0.04	0.02	85.49
capex to depreciation	0	1.97	-100.00
stock based compensation to revenue	0.0	0.0	145.46
graham number	634.19	544.28	16.52
roic	0.22	0.21	6.32
return on tangible assets	0.15	0.12	26.81
graham net net	-86.73	-50.0	-73.47
working capital	16763360000000	16817404000000	-0.32
tangible asset value	29809430000000	28109745000000	6.05
net current asset value	14619633000000	14746174000000	-0.86
invested capital	26396771000000	23575256000000	11.97
average receivables	9587293000000	9393242000000	2.07
average payables	5530626500000	3858701000000	43.33
average inventory	16124386000000	12234169000000	31.80
days sales outstanding	25.6	52.15	-50.91
days payables outstanding	87.68	17.0	415.91
days of inventory on hand	266.24	46.42	473.61
receivables turnover	14.26	7.0	103.71
payables turnover	4.16	21.48	-80.62
inventory turnover	1.37	7.86	-82.57
roe	0.27	0.22	20.75
capex per share	14.63	18.73	-21.89

• Positive

  ROE: Return on Equity (ROE) increased to 0.27 on 2023-12-31 from 0.22 on 2022-12-31, representing a change of 20.75%. Suggesting the company has been generating high returns for its shareholders.

  Current Ratio: Current Ratio increased to 1.72 on 2023-12-31 from 1.69 on 2022-12-31, representing a change of 2.03%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.01 on 2023-12-31 from 0.02 on 2022-12-31, representing a change of -13.35%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 12.79 on 2023-12-31 from 15.45 on 2022-12-31, representing a change of -17.25%. Indicating a decrease in the relative valuation of the company's stock.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
PHJMF
calendar year	2024	2024	NaN
revenue per share	263.51	95.89	174.80
net income per share	16.4	9.2	78.34
operating cash flow per share	24.22	45.24	-46.48
free cash flow per share	21.51	39.26	-45.21
cash per share	51.83	60.63	-14.52
book value per share	232.4	215.84	7.67
tangible book value per share	231.88	215.32	7.69
shareholders equity per share	232.4	215.84	7.67
interest debt per share	3.45	4.43	-22.25
market cap	88401738444000	81422653830000	8.57
enterprise value	82763520444000	74878433830000	10.53
pe ratio	11.58	19.03	-39.12
price to sales ratio	2.88	7.3	-60.49
pocfratio	31.39	15.47	102.85
pfcf ratio	35.33	17.83	98.16
pb ratio	3.27	3.24	0.84
ptb ratio	3.27	3.24	0.84
ev to sales	2.7	6.71	-59.78
enterprise value over ebitda	30.1	44.91	-32.99
ev to operating cash flow	29.38	14.23	106.51
ev to free cash flow	33.08	16.4	101.74
earnings yield	0.02	0.01	64.26
free cash flow yield	0.03	0.06	-49.54
debt to equity	0.01	0.02	-28.63
debt to assets	0.01	0.01	-26.37
net debt to ebitda	-2.05	-3.93	47.76
current ratio	1.57	1.52	3.00
interest coverage	242.92	168.61	44.07
income quality	1.48	4.92	-69.99
dividend yield	0	0.1	-100.00
payout ratio	0	7.54	-100.00
sales general and administrative to revenue	0.02	0.07	-66.11
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0.0	0.0	-4.18
capex to operating cash flow	0.11	0.13	-15.52
capex to revenue	0.01	0.06	-83.55
capex to depreciation	1.07	2.33	-53.86
stock based compensation to revenue	0	0.0	-100.00
graham number	292.85	211.33	38.57
roic	0.06	0.03	92.64
return on tangible assets	0.04	0.02	70.89
graham net net	-22.99	-56.37	59.22
working capital	13661319000000	12366330000000	10.47
tangible asset value	26972164000000	25046014000000	7.69
net current asset value	11592114000000	10224592000000	13.37
invested capital	23244380000000	22092900000000	5.21
average receivables	7069576000000	4083395000000	73.13
average payables	5047966500000	5282091000000	-4.43
average inventory	19215428000000	19485915500000	-1.39
days sales outstanding	31.08	28.67	8.43
days payables outstanding	18.25	60.51	-69.84
days of inventory on hand	67.36	237.78	-71.67
receivables turnover	2.9	3.14	-7.77
payables turnover	4.93	1.49	231.52
inventory turnover	1.34	0.38	253.01
roe	0.07	0.04	65.64
capex per share	2.71	5.99	-54.78

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 11.58 on 2024-09-30 Q3 from 19.03 on 2024-06-30 Q2, representing a change of -39.12%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 1.57 on 2024-09-30 Q3 from 1.52 on 2024-06-30 Q2, representing a change of 3.00%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.01 on 2024-09-30 Q3 from 0.02 on 2024-06-30 Q2, representing a change of -28.63%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Neutral Sentiment: Discounted Cash Flow value is 0.04 which is equal to current price 0.04, indicates the company may be fairly valued.